JOHANNESBURG - Lenacapavir is described as a gamechanger in the fight against HIV/Aids. The long-acting prevention injection ...
Zimbabwe is among 10 nations rolling out lenacapavir, a twice-yearly HIV prevention shot. "We are excited to announce that ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
KZN to receive Lenacapavir,new long-acting HIV prevention injection. Minister Motsoaledi confirms rollout to 360 clinics, for ...
The AHF Global Public Health Institute for Latin America and the Caribbean, in collaboration with the National Institute of ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
allAfrica.com on MSN
'Miracle' HIV shot rollout in Zimbabwe sparks debate
Zimbabwe is among 10 nations rolling out lenacapavir, a twice-yearly HIV prevention shot. Experts have called it a ...
The South African on MSN
Lenacapavir rollout in South Africa and PEPFAR builds momentum
South Africa advances HIV prevention with the lenacapavir rollout in 2026, and the US approves the PEPFAR Bridge Plan for six ...
O AHF Global Public Health Institute para a América Latina e Caribe, em parceria com o Instituto Nacional de Saúde Pública do ...
4don MSNOpinion
The only thing standing between humanity and the end of HIV
A new drug called lenacapavir might entirely change the game, though.
Lenacapavir is a breakthrough long-acting HIV prevention drug, which Motsoaledi has labelled a turning point in the country’s ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback